Alexza (ALXA) -34.4% premarket after it says its new drug application for Adasuve, a...

|About: Alexza Pharmaceuticals, Inc. (ALXA)|By:, SA News Editor

Alexza (ALXA) -34.4% premarket after it says its new drug application for Adasuve, a schizophrenic and bipolar disorder treatment, can't be approved by the FDA until a deficiency at a manufacturing facility for the application is resolved.